GR861242B - Method for preparing a compound constituted of a s. mutans adhesive wall which has a protein nature and of a s. mutans polysaccharide and its use as anti-caries vaccine - Google Patents

Method for preparing a compound constituted of a s. mutans adhesive wall which has a protein nature and of a s. mutans polysaccharide and its use as anti-caries vaccine

Info

Publication number
GR861242B
GR861242B GR861242A GR860101242A GR861242B GR 861242 B GR861242 B GR 861242B GR 861242 A GR861242 A GR 861242A GR 860101242 A GR860101242 A GR 860101242A GR 861242 B GR861242 B GR 861242B
Authority
GR
Greece
Prior art keywords
mutans
preparing
polysaccharide
protein nature
adhesive wall
Prior art date
Application number
GR861242A
Other languages
English (en)
Inventor
Frank Robert
Klein Jean-Paul
Ackermans Fabienne
Bazin Herve
Original Assignee
Univ Catholique Louvain
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Catholique Louvain, Inst Nat Sante Rech Med filed Critical Univ Catholique Louvain
Publication of GR861242B publication Critical patent/GR861242B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GR861242A 1985-05-14 1986-05-13 Method for preparing a compound constituted of a s. mutans adhesive wall which has a protein nature and of a s. mutans polysaccharide and its use as anti-caries vaccine GR861242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507315A FR2581877B1 (fr) 1985-05-14 1985-05-14 Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries

Publications (1)

Publication Number Publication Date
GR861242B true GR861242B (en) 1986-08-27

Family

ID=9319266

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861242A GR861242B (en) 1985-05-14 1986-05-13 Method for preparing a compound constituted of a s. mutans adhesive wall which has a protein nature and of a s. mutans polysaccharide and its use as anti-caries vaccine

Country Status (10)

Country Link
US (1) US4789735A (el)
EP (1) EP0206852A1 (el)
JP (1) JPS6226236A (el)
AU (1) AU598190B2 (el)
DK (1) DK221586A (el)
ES (1) ES8704350A1 (el)
FR (1) FR2581877B1 (el)
GR (1) GR861242B (el)
PT (1) PT82575B (el)
ZA (1) ZA863572B (el)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
EP0380084A3 (en) * 1989-01-27 1991-03-13 The Biomembrane Institute Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions
US5071977A (en) * 1989-05-10 1991-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5190746A (en) * 1989-05-10 1993-03-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5422427A (en) * 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
AU3065892A (en) * 1991-11-14 1993-06-15 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pneumococcal fimbrial protein a vaccines
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6312944B1 (en) 1991-11-14 2001-11-06 The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein A
ES2160601T3 (es) * 1992-09-24 2001-11-16 Brigham & Womens Hospital Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6235487B1 (en) 1995-11-03 2001-05-22 Stephen Holland Method of diagnosing Crohn's disease
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
JP2002511422A (ja) 1998-04-10 2002-04-16 リーズ，アンドリュー う食症予防用のコンジュゲートワクチン
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6803448B1 (en) * 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
US8609614B2 (en) 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
WO2003015815A1 (en) 2001-08-21 2003-02-27 The Brigham And Women's Hospital, Inc. Improved conjugate vaccines
AU2003257003A1 (en) * 2002-07-30 2004-02-16 Baxter Healthcare S.A. Chimeric multivalent polysaccharide conjugate vaccines
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
GB0313644D0 (en) * 2003-06-12 2003-07-16 Univ Bristol Inhibition of infection
WO2005044861A1 (en) * 2003-10-31 2005-05-19 Wyeth Holdings Corporation Polysaccharides of helicobacter pylori
AU2005236068C1 (en) 2004-04-21 2012-08-30 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
EP1812057A4 (en) 2004-11-01 2009-07-22 Brigham & Womens Hospital Modified Streptococci polysaccharides and their uses
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
WO2010083477A2 (en) 2009-01-16 2010-07-22 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal salmonella
WO2020163512A1 (en) 2019-02-05 2020-08-13 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794413B (en) * 1978-09-01 1980-08-27 Us Government Protection against dental caries
EP0068660B1 (en) * 1981-06-19 1985-04-17 Secretary of State for Social Services in Her Britannic Majesty's Gov. of the U.K. of Great Britain and Northern Ireland Protection against dental caries
JPS59151847A (ja) * 1982-03-25 1984-08-30 Kitasato Inst:The 非う蝕性組成物および飲料
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
GB8303994D0 (en) * 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates

Also Published As

Publication number Publication date
AU5741286A (en) 1986-12-18
JPS6226236A (ja) 1987-02-04
DK221586D0 (da) 1986-05-13
FR2581877B1 (fr) 1987-12-18
EP0206852A1 (fr) 1986-12-30
ES554864A0 (es) 1987-04-16
US4789735A (en) 1988-12-06
DK221586A (da) 1986-11-15
ZA863572B (en) 1987-07-29
AU598190B2 (en) 1990-06-21
PT82575A (fr) 1986-06-01
FR2581877A1 (fr) 1986-11-21
PT82575B (fr) 1987-09-22
ES8704350A1 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
GR861242B (en) Method for preparing a compound constituted of a s. mutans adhesive wall which has a protein nature and of a s. mutans polysaccharide and its use as anti-caries vaccine
AU569946B2 (en) Multivalent pneumococcal vaccine
IT8622282A0 (it) Metodi per la preparazione di medicazioni.
GB8907914D0 (en) Vaccine preparation
FI883783L (fi) Menetelmä nasaalivalmisteiden valmistamiseksi
ES555668A0 (es) Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd
IT8522564A0 (it) Procedimento per la preparazione di idroalofluoroalcani.
GR861071B (en) Method for the preparation of novel glycopeptide derivatives
EG17878A (en) Vaccine
GR860352B (en) Vaccine
ZA862145B (en) Non-adjuvenated vaccine
AU7774287A (en) Aqueous fluids
ZA872532B (en) Combined vaccine
ZW22487A1 (en) Vaccine
AU6524386A (en) Method for administering vaccines and compositions therefor
AU7395987A (en) Vaccine
AU586299B2 (en) Vaccine against mumps and process for its preparation
AU1349588A (en) Synthetic anti-caries vaccine
IT1187655B (it) Procedimento per la preparazione di w-lattami,in particolare caprolattame
IT8620761A0 (it) Procedimento per la preparazione di 2-bromo-alfa-ergocriptina.
AU7121281A (en) Chlamydous vaccine
AU7453687A (en) Novel vaccines
AU5970786A (en) Tick vaccine
ZA866843B (en) Vaccine against mumps and process for its preparation
PH22804A (en) Non-adjuvenated vaccine